Display Settings:


Send to:

Choose Destination
Stereotact Funct Neurosurg. 1997;69(1-4 Pt 2):243-6.

gamma-Amino-beta-hydroxybutyric acid as add-on therapy in adult patients with severe focal epilepsy.

Author information

  • 1Centro Médico Osler, Monterrey, N.L., México.


Total seizure frequency was evaluated among adult patients with severe partial epilepsy refractory to medical treatment. Clinical status was assessed before, and after a synthetic analog of gamma-amino-beta-hydroxybutyric acid (GABOB) was used as add-on therapy. Twenty-five patients with temporal and frontal lobe epilepsy were included in the trial. They received GABOB 250 mg twice daily during a 26-week period. Concentrations of concomitant antiepileptic medication were not modified. Twenty-five percent of the patients showed a 50% reduction of the total seizure frequency. There were no serious adverse effects related to medication.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk